Literature DB >> 9333108

Familial studies of heritability of alpha1-adrenergic receptor responsiveness in superficial veins.

A Gupta1, S G Carruthers.   

Abstract

BACKGROUND: Studies of monozygotic and dizygotic twins indicate an important genetic influence on the variability of responsiveness to norepinephrine in superficial human vein.
OBJECTIVES: Genetic aspects of variability of alpha1-adrenergic receptor responsiveness to norepinephrine in superficial veins were further investigated by studying the response to norepinephrine in the dorsal hand veins of parents and their children.
METHODS: Subjects were healthy nonsmoking adults (n = 24; age range, 40 to 52 years) and their biological children (n = 20; age range, 15 to 26 years) who were free from medications likely to modify vascular tone. Superficial vein responsiveness to norepinephrine was assessed by the linear variable differential transformer technique. The dose of norepinephrine required to constrict superficial vein diameter by 50% from baseline (ED50) was calculated for each subject. Heritability was estimated by standard techniques of regression of mid-parent/child (natural logarithm) ED50 values.
RESULTS: ED50 ranged from 5.6 to 254.6 ng/min in the parents and from 7.8 to 242.3 ng/min in the children. Heritability was calculated at 0.88.
CONCLUSIONS: These data confirm wide variability in superficial vein responsiveness to norepinephrine. The results confirm a major genetic influence in biological responsiveness of superficial vein to norepinephrine in healthy humans. Heritability of vascular alpha-adrenergic receptor responsiveness may influence vascular regulation during sympathetic stimulation and blockade.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333108     DOI: 10.1016/S0009-9236(97)90035-7

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  A polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction.

Authors:  Jussi P Posti; Perttu Salo; Saku Ruohonen; Laura Valve; Mordechai Muszkat; Gbenga G Sofowora; Daniel Kurnik; C Michael Stein; Markus Perola; Mika Scheinin; Amir Snapir
Journal:  Pharmacogenet Genomics       Date:  2013-03       Impact factor: 2.089

2.  Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction.

Authors:  A Adefurin; L V Ghimire; U Kohli; M Muszkat; G G Sofowora; C Li; S Y Paranjape; C M Stein; D Kurnik
Journal:  Pharmacogenomics J       Date:  2014-11-25       Impact factor: 3.550

3.  Genetic variation in the alpha1B-adrenergic receptor and vascular response.

Authors:  A Adefurin; L V Ghimire; U Kohli; M Muszkat; G G Sofowora; C Li; R T Levinson; S Y Paranjape; C M Stein; D Kurnik
Journal:  Pharmacogenomics J       Date:  2016-04-19       Impact factor: 3.550

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.